RSV F vaccine with adjuvant

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal ImmunizationNCT02624947NovavaxPhase 3Completed2018-12-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.